Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ilex MedicalXTAE:ILX 69 5-Year Yield-on-Cost % is 3.85 as of Aug. 23, 2026, which is 22% above its 10-year median of 3.15. GuruFocus rates XTAE:ILX with a GF Score™ of 69/100 and a GF Value™ of ₪63.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Ilex Medical ranks better than 68.25% on this metric.
Ilex Medical's yield on cost for the quarter that ended in Mar. 2026 was 3.85.
The historical rank and industry rank for Ilex Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
XTAE:ILX'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.67 Med: 3.15 Max: 7.85
Current: 3.85
During the past 13 years, Ilex Medical's highest Yield on Cost was 7.85. The lowest was 1.67. And the median was 3.15.
XTAE:ILX's 5-Year Yield-on-Cost % is ranked better than 68.25% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.38
vs XTAE:ILX: 3.85
Ilex Medical (XTAE:ILX) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Ilex Medical 5-Year Yield-on-Cost % Related Terms
XTAE:ILX vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Ilex Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ilex Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Ilex Medical's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Ilex Medical is calculated as
Ilex Medical (XTAE:ILX) has a 5-Year Yield-on-Cost % of 3.85 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ilex Medical and its competitors. This is 22% above median its historical median of 3.15. Over the past decade, Ilex Medical's 5-Year Yield-on-Cost % has ranged from 1.67 to 7.85. According to the industry distribution chart, Ilex Medical ranks #100 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Ilex Medical's 5-Year Yield-on-Cost % too high?
Ilex Medical's current 5-Year Yield-on-Cost % of 3.85 is 22% above median its 10-year median of 3.15. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 7.85. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.38. Ilex Medical's value of 3.85 is 61.8% above this industry median. Based on the distribution chart, Ilex Medical ranks #100 out of 315 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ilex Medical has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ilex Medical's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ilex Medical ranks #100 out of 315 companies for 5-Year Yield-on-Cost %. This puts Ilex Medical in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.38. Ilex Medical's value of 3.85 is 61.8% above this benchmark. Historically, Ilex Medical's own 5-Year Yield-on-Cost % has ranged from 1.67 to 7.85 over the past decade. While the company's 10-year median is 3.15 vs. the industry median of 2.38, Ilex Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.38, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ilex Medical's current 5-Year Yield-on-Cost % of 3.85 is 61.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ilex Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ilex Medical's current 5-Year Yield-on-Cost % is 3.85, which is 22% above median its own 10-year median of 3.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ilex Medical stock overvalued right now?
Based on GuruFocus' analysis, Ilex Medical (XTAE:ILX) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪63.68, compared to a current price of ₪51.60 — trading 19% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.85, which is 22% above median its 10-year median of 3.15 and 61.8% above the Medical Devices & Instruments industry median of 2.38. Ilex Medical's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ilex Medical (XTAE:ILX), the current 5-Year Yield-on-Cost % is 3.85 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ilex Medical (XTAE:ILX) Overvalued in 2026?
Based on GuruFocus' analysis, Ilex Medical stock appears to be undervalued.
The current stock price of ₪51.60 is trading 19% below its estimated GF Value™ of ₪63.68.
GuruFocus considers Ilex Medical to be Modestly Undervalued.
Key valuation signals for XTAE:ILX:
5-Year Yield-on-Cost %: 3.85 (22% above median its 10-year median of 3.15)
GF Value™: ₪63.68 vs. price of ₪51.60 (19% below fair value)
Industry Position: 61.8% above the Medical Devices & Instruments median (#100 of 315)
No single metric tells the full story. See the XTAE:ILX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
69GF Score
Get the complete analysis for XTAE:ILX
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ILX has been successfully added to your 
